Zacks Investment Research on MSN6d
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
Zimmer Biomet's ZBH fourth-quarter 2025 performance was driven by its market expansion efforts. The company’s robust Knee business looks promising for growth. Meanwhile, a dull macroeconomic scenario ...
Zacks.com on MSN4mon
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues
The company is currently focusing on ROSA Robotic Platform combined with its Persona cementless Knee. According to Zimmer ...
The Victoria Advocate18d
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona ® Revision SoluTion™ Femur, and Debut of ...
Zimmer Biomet Focuses on Innovation Amid Growing Competition
Among Zimmer Biomet's knee solutions featured at the AAOS 2025, the newly cleared Persona Revision SoluTion Femur is expected to draw attention.
London South East3y
Smith & Nephew Share News (SN.)
Orlando, Florida-based medical equipment manufacturer Engage Surgical is the owner of the Engage Surgical Partial Knee System, it said. The medical product is a cementless knee implant that is ...
Nasdaq14d
Zimmer Biomet Focuses on Innovation Amid Growing Competition
Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is ...